Your session is about to expire
← Back to Search
Narrow Band Imaging for Gastric Neoplasia
N/A
Recruiting
Led By James Buxbaum, MD
Research Sponsored by University of Southern California
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up one year
Awards & highlights
Study Summary
This trial will help determine whether using narrow band imaging to detect gastric cancer precursors leads to earlier detection and treatment of the disease.
Eligible Conditions
- Gastric Dysplasia
- Stomach Cancer
- Gastric Metaplasia
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ one year
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~one year
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Detection of Intestinal Metaplasia or Dysplasia
Secondary outcome measures
Biopsies driven by method
Helicobacter pyrlori detection
Number of Regions with Intestinal Metaplasia
+1 moreTrial Design
1Treatment groups
Experimental Treatment
Group I: Gastric SymptomsExperimental Treatment3 Interventions
Patients with gastric symptoms including dyspepsia undergoing upper endoscopy will undergo white light biopsy narrow band imaging guided biopsy protocolled biopsy
Find a Location
Who is running the clinical trial?
University of Southern CaliforniaLead Sponsor
905 Previous Clinical Trials
1,596,098 Total Patients Enrolled
Universidade do PortoOTHER
146 Previous Clinical Trials
61,661 Total Patients Enrolled
James Buxbaum, MDPrincipal InvestigatorUniversity of Southern California
6 Previous Clinical Trials
890 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You have symptoms of stomach pain, indigestion, abnormal stomach images, low iron levels in your blood, stomach ulcers, or weight loss related to stomach problems.
Research Study Groups:
This trial has the following groups:- Group 1: Gastric Symptoms
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger